Abstract Purpose of Review Acute myeloid leukemia (AML) in children remains a
challenging disease to cure with suboptimal outcomes particularly when compared to the …

Acute myeloid leukemia (AML) accounts for 25% of pediatric leukemia and affects
approximately 180 patients annually in Japan. The treatment outcome for pediatric AML has …

Opinion statement Despite the use of intensive chemotherapy and hematopoietic stem cell
transplantation, approximately one-third of children with acute myeloid leukemia (AML) still …

Further incorporation of genomic and molecular data in pediatric AML will allow for
additional refinements in risk stratification to enable the tailoring of treatment intensity. These …

The outcome for children with acute myeloid leukemia (AML) has improved significantly over
the past 30 years, with complete remission and overall survival rates exceeding 90 and …

Although acute myeloid leukaemia (AML) has long been recognized for its morphological
and cytogenetic heterogeneity, recent high‐resolution genomic profiling has demonstrated a …

Although acute myelogenous leukemia (AML) accounts for< 20% of leukemia in children, it
is responsible for over half of all pediatric leukemia deaths. Improvement in event-free …

JCM | Free Full-Text | Pediatric Acute Myeloid Leukemia&mdash;Past, Present, and Future Next
Article in Journal Sexual Habits and Sexual Dysfunctions in a Sample of Patients with Psychotic …

Acute myeloid leukaemia (AML) is characterized by a block in differentiation and an
unregulated proliferation of myeloid progenitor cells. While the cause of AML in children is …

Prognosis of childhood acute myeloid leukemia (AML) has improved significantly over the
past decades, from nearly no child surviving to a present probability of cure of approximately …